Work

RXR agonist IRX4204 enhances BCMA CAR-T-cell efficacy by suppressing ferroptosis via CHAC1 downregulation

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-3947

Authors: Jian Wu, Ying Zhou, Kimberly Burcher, Louisa Wirthlin, Jen Makepeace, Pamela Noldner, Pradyot Dash, Mikhail Nikiforov, Beth Shaz, Vidyasagar Vuligonda, Martin Sanders, Yubin Kang

Institutions: Duke University, Duke Medical Center, Lentigen Technology (United States)

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417004709

Cites:

Cited by:

Related to: